We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Hill Dermaceuticals Gets 483 for Several GMP Issues
Hill Dermaceuticals Gets 483 for Several GMP Issues
January 6, 2011
The FDA has given Hill Dermaceuticals a Form 483 after an inspection revealed several GMP deviations, such as failure to perform adequate and thorough investigations and to propose adequate corrective actions.